Form 4: Twist Bioscience COO Sells Shares for Tax Obligations

Twist Bioscience's President and COO, Patrick John Finn, sold 23,747 shares of common stock at $32.187 per share to cover tax withholding obligations related to vested Performance Stock Units.

Summary

• Patrick John Finn, President and COO of Twist Bioscience Corp (TWST), reported a sale of common stock.
• The transaction involved the disposition of 23,747 shares of common stock on October 6, 2025.
• The shares were sold at a price of $32.187 per share.
• Following this transaction, Patrick John Finn beneficially owns 208,735 shares of common stock.
• The sale was a 'sell to cover' transaction, mandated by the Issuer's equity incentive plans, to satisfy tax withholding obligations in connection with the vesting of Performance Stock Units (PSUs).
• This sale does not represent a discretionary trade by the Reporting Person.

Sentiment

Score: 5

Explanation: The sentiment is neutral. The transaction is a routine, non-discretionary 'sell to cover' event for tax purposes related to vested equity, which is a common occurrence in executive compensation and does not reflect a change in the executive's investment conviction or the company's fundamental outlook.

Positives

• The transaction indicates the vesting of Performance Stock Units (PSUs), which suggests the executive met performance criteria.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Management Comments

• The sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Industry Context

This type of 'sell to cover' transaction is a common practice in executive compensation across various industries, where shares are sold to meet tax obligations upon the vesting of equity awards like Performance Stock Units (PSUs). It reflects standard compensation plan mechanics rather than a discretionary investment decision.

Stakeholder Impact

• Shareholders: The sale represents a minor dilution of ownership but is a standard, non-discretionary event for tax purposes, unlikely to significantly impact shareholder sentiment.
• Employees: The vesting of PSUs and subsequent tax-related sale is a common aspect of executive compensation, aligning with typical equity incentive plan structures.

Key Dates

Recommendation

This Form 4 filing details a non-discretionary 'sell to cover' transaction by an executive to satisfy tax obligations upon the vesting of Performance Stock Units. Such routine transactions are common and generally do not signal a change in the company's fundamentals or the executive's long-term view. Therefore, it does not provide new information that would warrant a change from a 'hold' recommendation, assuming the previous recommendation was 'hold'.

Keywords

Twist Bioscience, TWST, Form 4, Insider Transaction, Stock Sale, Executive Compensation, Patrick John Finn, Sell to Cover, Performance Stock Units